Europlasma S.A. (LON:0W8R)

Europlasma Statistics

Total Valuation

Europlasma has a market cap or net worth of GBP 91,035. The enterprise value is 4.34 million.

Market Cap	91,035
Enterprise Value	4.34M

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.50M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.00
PB Ratio	-0.01
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.11
EV / Sales	0.08
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.19

Financial Position

The company has a current ratio of 0.80

Current Ratio	0.80
Quick Ratio	0.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-0.66
Interest Coverage	-3.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-22.66%
Return on Invested Capital (ROIC)	-351.37%
Return on Capital Employed (ROCE)	-164.80%
Weighted Average Cost of Capital (WACC)	38.71%
Revenue Per Employee	129,535
Profits Per Employee	-95,801
Employee Count	398
Asset Turnover	0.78
Inventory Turnover	1.80

Taxes

Income Tax	-1.82M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.54% in the last 52 weeks. The beta is 0.40, so Europlasma's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-99.54%
50-Day Moving Average	20.32
200-Day Moving Average	4,724.00
Relative Strength Index (RSI)	20.61
Average Volume (20 Days)	132

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Europlasma had revenue of GBP 51.56 million and -38.13 million in losses. Loss per share was -274.65.

Revenue	51.56M
Gross Profit	22.37M
Operating Income	-23.95M
Pretax Income	-41.43M
Net Income	-38.13M
EBITDA	-13.75M
EBIT	-23.95M
Loss Per Share	-274.65

Balance Sheet

The company has 9.01 million in cash and 14.78 million in debt, with a net cash position of -5.77 million.

Cash & Cash Equivalents	9.01M
Total Debt	14.78M
Net Cash	-5.77M
Net Cash Per Share	n/a
Equity (Book Value)	-17.83M
Book Value Per Share	-29.03
Working Capital	-11.55M

Cash Flow

In the last 12 months, operating cash flow was -19.37 million and capital expenditures -3.03 million, giving a free cash flow of -22.40 million.

Operating Cash Flow	-19.37M
Capital Expenditures	-3.03M
Free Cash Flow	-22.40M
FCF Per Share	n/a

Margins

Gross margin is 43.39%, with operating and profit margins of -46.46% and -73.96%.

Gross Margin	43.39%
Operating Margin	-46.46%
Pretax Margin	-80.36%
Profit Margin	-73.96%
EBITDA Margin	-26.68%
EBIT Margin	-46.46%
FCF Margin	n/a

Dividends & Yields

Europlasma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-41,883.83%
FCF Yield	-24,604.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 28, 2024. It was a reverse split with a ratio of 0.0002.

Last Split Date	May 28, 2024
Split Type	Reverse
Split Ratio	0.0002

Scores

Europlasma has an Altman Z-Score of -4.76 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.76
Piotroski F-Score	2